Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 7 studies | 30% ± 10% |
Insufficient scRNA-seq data for expression of GDF10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 78% | 416.69 | 2057 / 2642 | 74% | 10.53 | 521 / 705 |
lung | 99% | 2297.00 | 570 / 578 | 45% | 2.36 | 518 / 1155 |
thymus | 95% | 1234.37 | 623 / 653 | 37% | 2.75 | 224 / 605 |
breast | 94% | 1204.36 | 432 / 459 | 38% | 2.34 | 428 / 1118 |
pancreas | 96% | 793.38 | 314 / 328 | 28% | 0.59 | 49 / 178 |
adrenal gland | 31% | 101.13 | 79 / 258 | 66% | 42.48 | 152 / 230 |
blood vessel | 91% | 900.21 | 1209 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 77% | 714.31 | 1115 / 1445 | 6% | 0.17 | 11 / 183 |
adipose | 72% | 887.01 | 870 / 1204 | 0% | 0 | 0 / 0 |
intestine | 44% | 168.93 | 429 / 966 | 17% | 1.43 | 92 / 527 |
stomach | 32% | 158.36 | 116 / 359 | 29% | 4.11 | 82 / 286 |
bladder | 48% | 129.95 | 10 / 21 | 12% | 0.71 | 58 / 504 |
prostate | 40% | 245.48 | 97 / 245 | 20% | 0.57 | 98 / 502 |
uterus | 44% | 320.73 | 74 / 170 | 15% | 1.83 | 70 / 459 |
skin | 38% | 176.56 | 691 / 1809 | 20% | 0.64 | 94 / 472 |
heart | 41% | 189.71 | 349 / 861 | 0% | 0 | 0 / 0 |
ovary | 3% | 9.22 | 6 / 180 | 22% | 2.45 | 96 / 430 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.24 | 5 / 29 |
liver | 0% | 1.16 | 1 / 226 | 16% | 0.93 | 65 / 406 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.62 | 7 / 45 |
muscle | 15% | 52.22 | 119 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 10% | 0.24 | 86 / 901 |
eye | 0% | 0 | 0 / 0 | 3% | 0.37 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021549 | Biological process | cerebellum development |
GO_0001501 | Biological process | skeletal system development |
GO_0030278 | Biological process | regulation of ossification |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0042698 | Biological process | ovulation cycle |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_1904373 | Biological process | response to kainic acid |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005125 | Molecular function | cytokine activity |
GO_0008083 | Molecular function | growth factor activity |
Gene name | GDF10 |
Protein name | Growth/differentiation factor 10 (GDF-10) (Bone morphogenetic protein 3B) (BMP-3B) (Bone-inducing protein) (BIP) |
Synonyms | BMP3B |
Description | FUNCTION: Growth factor involved in osteogenesis and adipogenesis. Plays an inhibitory role in the process of osteoblast differentiation via SMAD2/3 pathway. Plays an inhibitory role in the process of adipogenesis. . |
Accessions | ENST00000580279.2 P55107 |